The fact
Trading forums discuss a potential rebound to €0.080.
The stock remains volatile in a highly speculative biotech sector.
Click the link to read an article on the topic:
Trading forums discuss a potential rebound to €0.080.
The stock remains volatile in a highly speculative biotech sector.